drugset / Trial / NCT04214990
Aspirin Use for Gastric Cancer Prevention in the Early Gastric Cancer Patients
Phase 3
Recruiting
1700 enrolled
National Cancer Center, Korea
Asan Medical Center · collabChilgok Kyungpook National University · collabChonnam National University Hospital · collabChung-Ang University Hospital · collabHallym University Medical Center · collabIncheon St.Mary's Hospital/The Catholic University · collabKosin University Gospel Hospital · collabPusan National University Hospital · collabSMG-SNU Boramae Medical Center · collabSamsung Medical Center · collabSeoul National University Bundang Hospital · collabSeverance Hospital · collab
RandomizedParallel-groupQuadruple-blindPrevention
Summary
This study aimed to investigate the effect of low-dose (100 mg) asprin on the prevention of gastric cancer in the early gastric cancer patients with negative H. pylori status who underwent endoscopic submucosal dissection.
Timeline
- Start
- 2020-02-15
- Primary completion
- 2031-03-31
- Completion
- 2032-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Aspirin | Small molecule | 100 mg | — |